Glenmark Pharma Q3: Profit, revenue up over 15% as India, North America drive growth
Glenmark Pharmaceuticals posted strong Q3 results with profit and revenue rising over 15% YoY, aided by robust growth in India and North America and sharp…
Glenmark Pharmaceuticals posted strong Q3 results with profit and revenue rising over 15% YoY, aided by robust growth in India and North America and sharp…
While Birla Corp’s net profit and earnings before interest, tax, depreciation and amortisation (EBITDA) gained, its revenue declined.

The brokerage remains constructive on financials, telecom, consumer and industrial names, citing healthy earnings outlook and attractive upside potential across its key stock picks.

As per NTPC’s official website, the company boasts an installed capacity exceeding 85,000 MW at the group level, which includes coal, gas/liquid fuel, hydro, and…

The rupee fell to 90.12 against the US dollar on January 2, as persistent dollar demand and thin liquidity pressured the currency despite Reserve Bank…

Axis Mutual Fund’s Shreyash Devalkar said Indian equities are facing valuation pressure as most investment themes are already priced in. He is focusing on growth…

Analysts remain cautious on ITC after a sharp cigarette excise duty hike, warning of price increases, volume decline, and pressure on valuation due to a…

Under this revised framework, foreign buyers can participate along with domestic buyers in the auction. Earlier, access to foreign consumers was only through domestic coal…

Bharat Heavy Electricals Limited received tax relief as Telangana Commercial Tax Department dropped a ₹183.77 crore GST demand for FY22, with ₹1.43 crore remaining under…

Brokerage firm Morgan Stanley expects re-rating and earnings upgrades for RIL to play out through each quarter of 2026.